Hikal Launches Personal Care Production at Gujarat Facility
By ThePip Desk
Hikal begins commercial production of personal care and skin care products at its new cGMP-compliant Panoli facility in Gujarat, expanding into global markets.
Hikal has officially commenced commercial production in the Personal Care segment by commissioning a new multipurpose manufacturing facility at its Panoli, Gujarat site. This development marks the company’s formal entry into commercial-scale supply for the global beauty and personal care industry.
Key Production and Strategic Milestones
- Facility status: cGMP-compliant and multipurpose asset repurposed for the beauty and personal care sector.
- Initial product focus: Beauty and personal care segment, specifically the skin care category.
- Portfolio highlights: Second-generation UV filters offering enhanced performance and regulatory alignment.
The company stated that the newly commissioned facility has successfully manufactured its first production batches following its recent launch. Product samples have undergone customer validation, yielding encouraging feedback and positive market pull for the expanded portfolio.
Diversification Beyond Core Segments
- Core sectors: Established presence in Pharmaceuticals, Crop Protection, and growing Animal Healthcare.
- Value chain scope: Manufacturing of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities.
This expansion represents the latest step in Hikal’s broader strategy of building high-value growth platforms alongside its traditional business segments. As global customers continue to review product approvals, the company deepens its presence across the life sciences value chain.